ClinChoice
Molly Sang is an experienced finance professional currently serving as the Senior Vice President of Finance at ClinChoice, where Molly functions as the International Head of Finance since March 2019. Prior experience includes roles as Vice President of Finance at BTG plc and Global FP&A Director at Frontage Laboratories, Inc. Molly also held the position of Head of Finance at Teva Pharmaceuticals and served in various finance roles at Deloitte and KPMG. Educational qualifications include a Bachelor's degree from Peking University and an M.B.A. in Accounting from the University of St. Thomas.
ClinChoice
2 followers
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, Canada, India, Japan and the Philippines. It has over 4,000 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.